Plentiful PtdIns5P from scanty PtdIns(3,5)P2 or from ample PtdIns? PIKfyve-dependent models: Evidence and speculation (response to: DOI 10.1002/bies.201300012)

BioEssays

Volumn 37, Issue 3, 2015, Pages 267-277

  Shisheva, Assia ^a   Sbrissa, Diego ^a   Ikonomov, Ognian ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3 phosphatases; Direct PtdIns5P synthesis; Phosphoinositides; PIKfyve; PtdIns(3,5)P2; PtdIns(3,5)P2 PtdIns3P conversion; PtdIns3P

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; PHOSPHATE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 5 PHOSPHATE; UNCLASSIFIED DRUG; POLYPHOSPHOINOSITIDE;

ARTICLE; CATALYSIS; DEPHOSPHORYLATION; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; MAMMAL CELL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; ANIMAL; GENETICS; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

MAMMALIA;

ANIMALS; HUMANS; PHOSPHATIDYLINOSITOL PHOSPHATES; SIGNAL TRANSDUCTION;

EID: 84925394347     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201400129     Document Type: Article

References (90)

1. Di Paolo G, De Camilli P. 2006. Phosphoinositides in cell regulation and membrane dynamics. Nature 443: 651-7.
2. Shisheva A. 2012. PIKfyve and its lipid products in health and in sickness. Curr Top Microbiol Immunol 362: 127-62.
3. Hakim S, Bertucci MC, Conduit SE, Vuong DL, et al. 2012. Inositol polyphosphate phosphatases in human disease. Curr Top Microbiol Immunol 362: 247-314.
4. Balla T. 2013. Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol Rev 93: 1019-37.
5. Viaud J, Lagarrigue F, Ramel D, Allart S, et al. 2014. Phosphatidylinositol 5-phosphate regulates invasion through binding and activation of Tiam1. Nat Commun 5: 4080.
6. Yuan TL, Cantley LC. 2008. PI3K pathway alterations in cancer: variations on a theme. Oncogene 27: 5497-510.
7. Mayinger P. 2012. Phosphoinositides and vesicular membrane traffic. Biochim Biophys Acta 1821: 1104-13.
8. Sun Y, Thapa N, Hedman AC, Anderson RA. 2013. Phosphatidylinositol 4, 5-bisphosphate: targeted production and signaling. BioEssays 35: 513-22.
9. Rameh LE, Tolias KF, Duckworth BC, Cantley LC. 1997. A new pathway for synthesis of phosphatidylinositol-4, 5-bisphosphate. Nature 390: 192-6.
10. Leibiger B, Moede T, Uhles S, Barker CJ, et al. 2010. Insulin-feedback via PI3K-C2alpha activated PKBalpha/Akt1 is required for glucose-stimulated insulin secretion. FASEB J 24: 1824-37.
11. Falasca M, Maffucci T. 2012. Regulation and cellular functions of class II phosphoinositide 3-kinases. Biochem J 443: 587-601.
12. Bridges D, Ma JT, Park S, Inoki K, et al. 2012. Phosphatidylinositol 3, 5-bisphosphate plays a role in the activation and subcellular localization of mechanistic target of rapamycin 1. Mol Biol Cell 23: 2955-62.
13. Posor Y, Eichhorn-Gruenig M, Puchkov D, Schoneberg J, et al. 2013. Spatiotemporal control of endocytosis by phosphatidylinositol-3, 4-bisphosphate. Nature 499: 233-7.
14. Franco I, Gulluni F, Campa CC, Costa C, et al. 2014. PI3K class II alpha controls spatially restricted endosomal PtdIns3P and Rab11 activation to promote primary cilium function. Dev Cell 28: 647-58.
15. Shisheva A, Sbrissa D, Ikonomov O. 1999. Cloning, characterization, and expression of a novel Zn2+-binding FYVE finger-containing phosphoinositide kinase in insulin-sensitive cells. Mol Cell Biol 19: 623-34.
16. Sbrissa D, Ikonomov OC, Shisheva A. 1999. PIKfyve, a mammalian ortholog of yeast Fab1p lipid kinase, synthesizes 5-phosphoinositides. Effect of insulin. J Biol Chem 274: 21589-97.
17. Sbrissa D, Ikonomov OC, Shisheva A. 2000. PIKfyve lipid kinase is a protein kinase: downregulation of 5′-phosphoinositide product formation by autophosphorylation. Biochemistry 39: 15980-9.
18. Sbrissa D, Ikonomov OC, Deeb R, Shisheva A. 2002. Phosphatidylinositol 5-phosphate biosynthesis is linked to PIKfyve and is involved in osmotic response pathway in mammalian cells. J Biol Chem 277: 47276-84.
19. Ikonomov OC, Sbrissa D, Shisheva A. 2001. Mammalian cell morphology and endocytic membrane homeostasis require enzymatically active phosphoinositide 5-kinase PIKfyve. J Biol Chem 276: 26141-7.
20. Ikonomov OC, Sbrissa D, Mlak K, Kanzaki M, et al. 2002. Functional dissection of lipid and protein kinase signals of PIKfyve reveals the role of PtdIns 3, 5-P2 production for endomembrane integrity. J Biol Chem 277: 9206-11.
21. Morris JB, Hinchliffe KA, Ciruela A, Letcher AJ, et al. 2000. Thrombin stimulation of platelets causes an increase in phosphatidylinositol 5-phosphate revealed by mass assay. FEBS Lett 475: 57-60.
22. Sbrissa D, Ikonomov OC, Strakova J, Shisheva A. 2004. Role for a novel signaling intermediate, phosphatidylinositol 5-phosphate, in insulin-regulated F-actin stress fiber breakdown and GLUT4 translocation. Endocrinology 145: 4853-65.
23. Shisheva A. 2001. PIKfyve: the road to PtdIns 5-P and PtdIns 3, 5-P(2). Cell Biol Int 25: 1201-6.
24. McEwen RK, Dove SK, Cooke FT, Painter GF, et al. 1999. Complementation analysis in PtdInsP kinase-deficient yeast mutants demonstrates that Schizosaccharomyces pombe and murine Fab1p homologues are phosphatidylinositol 3-phosphate 5-kinases. J Biol Chem 274: 33905-12.
25. Gary JD, Wurmser AE, Bonangelino CJ, Weisman LS, et al. 1998. Fab1p is essential for PtdIns(3)P 5-kinase activity and the maintenance of vacuolar size and membrane homeostasis. J Cell Biol 143: 65-79.
26. Cooke FT, Dove SK, McEwen RK, Painter G, et al. 1998. The stress-activated phosphatidylinositol 3-phosphate 5-kinase Fab1p is essential for vacuole function in S. cerevisiae. Curr Biol 8: 1219-22.
27. Parrish WR, Stefan CJ, Emr SD. 2004. Essential role for the myotubularin-related phosphatase Ymr1p and the synaptojanin-like phosphatases Sjl2p and Sjl3p in regulation of phosphatidylinositol 3-phosphate in yeast. Mol Biol Cell 15: 3567-79.
28. Roberts HF, Clarke JH, Letcher AJ, Irvine RF, et al. 2005. Effects of lipid kinase expression and cellular stimuli on phosphatidylinositol 5-phosphate levels in mammalian cell lines. FEBS Lett 579: 2868-72.
29. Coronas S, Ramel D, Pendaries C, Gaits-Iacovoni F, et al. 2007. PtdIns5P: a little phosphoinositide with big functions? Biochem Soc Symp 74: 117-28.
30. Lecompte O, Poch O, Laporte J. 2008. PtdIns5P regulation through evolution: roles in membrane trafficking? Trends Biochem Sci 33: 453-60.
31. Ikonomov OC, Sbrissa D, Delvecchio K, Xie Y, et al. 2011. The phosphoinositide kinase PIKfyve is vital in early embryonic development: Preimplantation lethality of PIKfyve-/- embryos but normality of PIKfyve+/- mice. J Biol Chem 286: 13404-13.
32. Zolov SN, Bridges D, Zhang Y, Lee WW, et al. 2012. In vivo, Pikfyve generates PI(3, 5)P2, which serves as both a signaling lipid and the major precursor for PI5P. Proc Natl Acad Sci USA 109: 17472-7.
33. Sbrissa D, Shisheva A. 2005. Acquisition of unprecedented phosphatidylinositol 3, 5-bisphosphate rise in hyperosmotically stressed 3T3-L1 adipocytes, mediated by ArPIKfyve-PIKfyve pathway. J Biol Chem 280: 7883-9.
34. Sbrissa D, Ikonomov OC, Filios C, Delvecchio K, et al. 2012. Functional dissociation between PIKfyve-synthesized PtdIns5P and PtdIns(3, 5)P2 by means of the PIKfyve inhibitor YM201636. Am J Physiol Cell Physiol 303: C436-46.
35. Zhang Y, Zolov SN, Chow CY, Slutsky SG, et al. 2007. Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3, 5-bisphosphate, results in neurodegeneration in mice. Proc Natl Acad Sci USA 104: 17518-23.
36. McCartney AJ, Zhang Y, Weisman LS. 2014. Phosphatidylinositol 3, 5-bisphosphate: low abundance, high significance. BioEssays 36: 52-64.
37. Whiteford CC, Brearley CA, Ulug ET. 1997. Phosphatidylinositol 3, 5-bisphosphate defines a novel PI 3-kinase pathway in resting mouse fibroblasts. Biochem J 323: 597-601.
38. Cantley LC, Auger KR, Carpenter C, Duckworth B, et al. 1991. Oncogenes and signal transduction. Cell 64: 281-302.
39. Dove SK, Cooke FT, Douglas MR, Sayers LG, et al. 1997. Osmotic stress activates phosphatidylinositol-3, 5-bisphosphate synthesis. Nature 390: 187-92.
40. Sbrissa D, Ikonomov OC, Fu Z, Ijuin T, et al. 2007. Core protein machinery for mammalian phosphatidylinositol 3, 5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport. Novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex. J Biol Chem 282: 23878-91.
41. Botelho RJ, Efe JA, Teis D, Emr SD. 2008. Assembly of a Fab1 phosphoinositide kinase signaling complex requires the Figure 4 phosphoinositide phosphatase. Mol Biol Cell 19: 4273-86.
42. Jin N, Chow CY, Liu L, Zolov SN, et al. 2008. VAC14 nucleates a protein complex essential for the acute interconversion of PI3P and PI(3, 5)P(2) in yeast and mouse. EMBO J 27: 3221-34.
43. Shisheva A. 2013. PtdIns5P: news and views of its appearance, disappearance and deeds. Arch Biochem Biophys 538: 171-80.
44. Ikonomov OC, Sbrissa D, Dondapati R, Shisheva A. 2007. ArPIKfyve-PIKfyve interaction and role in insulin-regulated GLUT4 translocation and glucose transport in 3T3-L1 adipocytes. Exp Cell Res 313: 2404-16.
45. Xu Y, Lee SA, Kutateladze TG, Sbrissa D, et al. 2006. Chemical synthesis and molecular recognition of phosphatase-resistant analogues of phosphatidylinositol-3-phosphate. J Am Chem Soc 128: 885-97.
46. Sbrissa D, Ikonomov O, Shisheva A. 2001. Selective insulin-induced activation of class I(A) phosphoinositide 3-kinase in PIKfyve immune complexes from 3T3-L1 adipocytes. Mol Cell Endocrinol 181: 35-46.
47. Ikonomov OC, Sbrissa D, Mlak K, Shisheva A. 2002. Requirement for PIKfyve enzymatic activity in acute and long-term insulin cellular effects. Endocrinology 143: 4742-54.
48. Sbrissa D, Ikonomov OC, Strakova J, Dondapati R, et al. 2004. A mammalian ortholog of Saccharomyces cerevisiae Vac14 that associates with and up-regulates PIKfyve phosphoinositide 5-kinase activity. Mol Cell Biol 24: 10437-47.
49. Sbrissa D, Ikonomov OC, Fenner H, Shisheva A. 2008. ArPIKfyve homomeric and heteromeric interactions scaffold PIKfyve and Sac3 in a complex to promote PIKfyve activity and functionality. J Mol Biol 384: 766-79.
50. Ikonomov OC, Sbrissa D, Fenner H, Shisheva A. 2009. PIKfyve-ArPIKfyve-Sac3 core complex: contact sites and their consequence for Sac3 phosphatase activity and endocytic membrane homeostasis. J Biol Chem 284: 35794-806.
51. Fant X, Durieu E, Chicanne G, Payrastre B, et al. 2014. cdc-like/dual-specificity tyrosine phosphorylation-regulated kinases inhibitor leucettine L41 induces mTOR-dependent autophagy: implication for Alzheimer's disease. Mol Pharmacol 85: 441-50.
52. Ikonomov OC, Sbrissa D, Shisheva A. 2009. YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns(3, 5)P2 synthesis, halts glucose entry by insulin in adipocytes. Biochem Biophys Res Commun 382: 566-70.
53. Shisheva A. 2008. PIKfyve: partners, significance, debates and paradoxes. Cell Biol Int 32: 591-604.
54. Sbrissa D, Ikonomov OC, Shisheva A. 2002. Phosphatidylinositol 3-phosphate-interacting domains in PIKfyve. Binding specificity and role in PIKfyve. Endomenbrane localization. J Biol Chem 277: 6073-9.
55. Viaud J, Boal F, Tronchere H, Gaits-Iacovoni F, et al. 2014. Phosphatidylinositol 5-phosphate: a nuclear stress lipid and a tuner of membranes and cytoskeleton dynamics. BioEssays 36: 260-72.
56. Taylor GS, Maehama T, Dixon JE. 2000. Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc Natl Acad Sci USA 97: 8910-5.
57. Chaussade C, Pirola L, Bonnafous S, Blondeau F, et al. 2003. Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport. Mol Endocrinol 17: 2448-60.
58. Srivastava S, Li Z, Lin L, Liu G, et al. 2005. The phosphatidylinositol 3-phosphate phosphatase myotubularin- related protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel KCa3.1. Mol Cell Biol 25: 3630-8.
59. Cao C, Backer JM, Laporte J, Bedrick EJ, et al. 2008. Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafficking. Mol Biol Cell 19: 3334-46.
60. Vergne I, Roberts E, Elmaoued RA, Tosch V, et al. 2009. Control of autophagy initiation by phosphoinositide 3-phosphatase Jumpy. EMBO J 28: 2244-58.
61. Velichkova M, Juan J, Kadandale P, Jean S, et al. 2010. Drosophila Mtm and class II PI3K coregulate a PI(3)P pool with cortical and endolysosomal functions. J Cell Biol 190: 407-25.
62. Taguchi-Atarashi N, Hamasaki M, Matsunaga K, Omori H, et al. 2010. Modulation of local PtdIns3P levels by the PI phosphatase MTMR3 regulates constitutive autophagy. Traffic 11: 468-78.
63. Razidlo GL, Katafiasz D, Taylor GS. 2011. Myotubularin regulates Akt-dependent survival signaling via phosphatidylinositol 3-phosphate. J Biol Chem 286: 20005-19.
64. Davies E, Sheffield D, Tibarewal P, Fedele C, et al. 2012. The PTEN and myotubularin phosphoinositide 3-phosphatases: linking lipid signalling to human disease. In Balla T, Wymann M, York J, eds; Phosphoinositides I: Enzymes of Synthesis and Degradation. Springer. p. 281-336.
65. Jean S, Cox S, Schmidt EJ, Robinson FL, et al. 2012. Sbf/MTMR13 coordinates PI(3)P and Rab21 regulation in endocytic control of cellular remodeling. Mol Biol Cell 23: 2723-40.
66. Hnia K, Vaccari I, Bolino A, Laporte J. 2012. Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology. Trends Mol Med 18: 317-27.
67. Lu N, Shen Q, Mahoney TR, Neukomm LJ, et al. 2012. Two PI 3-kinases and one PI 3-phosphatase together establish the cyclic waves of phagosomal PtdIns(3)P critical for the degradation of apoptotic cells. PLoS Biol 10: e1001245.
68. Pulido R, Stoker AW, Hendriks WJ. 2013. PTPs emerge as PIPs: protein tyrosine phosphatases with lipid-phosphatase activities in human disease. Hum Mol Genet 22: R66-76.
69. Amoasii L, Hnia K, Chicanne G, Brech A, et al. 2013. Myotubularin and PtdIns3P remodel the sarcoplasmic reticulum in muscle in vivo. J Cell Sci 123: 1806-19.
70. Oppelt A, Lobert VH, Haglund K, Mackey AM, et al. 2013. Production of phosphatidylinositol 5-phosphate via PIKfyve and MTMR3 regulates cell migration. EMBO Rep 14: 57-64.
71. Vaccari I, Dina G, Tronchere H, Kaufman E, et al. 2011. Genetic interaction between MTMR2 and FIG4 phospholipid phosphatases involved in Charcot-Marie-Tooth neuropathies. PLoS Genet 7: e1002319.
72. Ikonomov OC, Filios C, Sbrissa D, Chen X, et al. 2013. The PIKfyve-ArPIKfyve-Sac3 triad in human breast cancer: functional link between elevated Sac3 phosphatase and enhanced proliferation of triple negative cell lines. Biochem Biophys Res Commun 440: 342-7.
73. Sarkes D, Rameh LE. 2010. A novel HPLC-based approach makes possible the spatial characterization of cellular PtdIns5P and other phosphoinositides. Biochem J 428: 375-84.
74. Clague MJ, Lorenzo O. 2005. The myotubularin family of lipid phosphatases. Traffic 6: 1063-9.
75. Amoasii L, Bertazzi DL, Tronchere H, Hnia K, et al. 2012. Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice. PLoS Genet 8: e1002965.
76. Coronas S, Lagarrigue F, Ramel D, Chicanne G, et al. 2008. Elevated levels of PtdIns5P in NPM-ALK transformed cells: implication of PIKfyve. Biochem Biophys Res Commun 372: 351-5.
77. Kawasaki T, Takemura N, Standley DM, Akira S, et al. 2013. The second messenger phosphatidylinositol-5-phosphate facilitates antiviral innate immune signaling. Cell Host Microbe 14: 148-58.
78. Jefferies HB, Cooke FT, Jat P, Boucheron C, et al. 2008. A selective PIKfyve inhibitor blocks PtdIns(3, 5)P(2) production and disrupts endomembrane transport and retroviral budding. EMBO Rep 9: 164-70.
79. Berg JM, Tymoszko JL, Stryer L. 2011. Biochemistry. New York: W.H. Freeman.
80. Best MD, Zhang H, Prestwich GD. 2010. Inositol polyphosphates, diphosphoinositol polyphosphates and phosphatidylinositol polyphosphate lipids: structure, synthesis, and development of probes for studying biological activity. Nat Prod Rep 27: 1403-30.
81. Cai X, Xu Y, Cheung AK, Tomlinson RC, et al. 2013. PIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signaling. Chem Biol 20: 912-21.
82. Hayakawa N, Noguchi M, Takeshita S, Eviryanti A, et al. 2014. Structure-activity relationship study, target identification, and pharmacological characterization of a small molecular IL-12/23 inhibitor, APY0201. Bioorg Med Chem 22: 3021-9.
83. Salamon RS, Backer JM. 2013. Phosphatidylinositol-3, 4, 5-trisphosphate: tool of choice for class I PI 3-kinases. BioEssays 35: 602-11.
84. Backer JM. 2008. The regulation and function of Class III PI3Ks: novel roles for Vps34. Biochem J 410: 1-17.
85. Schink KO, Raiborg C, Stenmark H. 2013. Phosphatidylinositol 3-phosphate, a lipid that regulates membrane dynamics, protein sorting and cell signalling. BioEssays 35: 900-12.
86. Stuffers S, Malerod L, Schink KO, Corvera S, et al. 2010. Time-resolved ultrastructural detection of phosphatidylinositol 3-phosphate. J Histochem Cytochem 58: 1025-32.
87. Shisheva A. 2008. Phosphoinositides in insulin action on GLUT4 dynamics: not just PtdIns(3, 4, 5)P3. Am J Physiol Endocrinol Metab 295: E536-44.
88. Rameh LE, Cantley LC. 1999. The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem 274: 8347-50.
89. Leslie NR, Downes CP. 2002. PTEN: the down side of PI 3-kinase signalling. Cell Signal 14: 285-95.
90. Ikonomov OC, Sbrissa D, Shisheva A. 2006. Localized PtdIns 3, 5-P2 synthesis to regulate early endosome dynamics and fusion. Am J Physiol Cell Physiol 291: C393-404.